Senior Science Editor
at Technology Networks
After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Education
Areas of Expertise
Got a Question for Anna MacDonald?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 341
Listicle
Creating Space in Science: LGBTQIA+ Voices on Belonging in Pharma
In this listicle, LGBTQIA+ scientists offer insights into how inclusion can be built into everyday lab culture, from normalizing pronoun sharing and celebrating diverse holidays to rethinking policy and representation.
Industry Insight
Unlocking the Potential of Minicircle DNA
In this interview, we explore the limitations of pDNA, the advantages of mcDNA and how NunaBio’s technology could unlock new possibilities for safer, more efficient gene therapy.
Industry Insight
Advancing QC for Complex Biologics
David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.
Industry Insight
How Is AI Shaping the Future of mRNA Therapeutics?
Learn more about how AI is advancing the mRNA drug discovery pipeline and what we can expect to see in the future in this interview with Dr. Davide De Lucrezia.
Industry Insight
Shaping the Future of Newborn Screening
Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.
Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Industry Insight
Unlocking the Potential of PROTACs in Drug Discovery
To explore how PROTACs are transforming drug discovery, we spoke with Robyn Stoller, business development manager at Cytiva.
Industry Insight
How Is the Cell and Gene Therapy Landscape Evolving?
To explore how the CGT landscape is evolving, Technology Networks spoke with Betty Woo, vice president of Cell, Gene and Advanced Therapies at Thermo Fisher Scientific.
Industry Insight
Driving Customer-Centric Innovation: Agilent’s Organizational Transformation
In this Q&A, Padraig McDonnell discusses how the reorganization aligns with Agilent’s commitment to innovation and customer success, the expected benefits of the new structure and the steps being taken to ensure a seamless transition.
Industry Insight
Unlocking the Human Proteome
We spoke with Dr. Michael Gonzales to learn more about the UKB-PPP and its goals, the technical hurdles of large-scale proteomics and how Olink technology is helping to overcome them.
Advertisement
